Tips to start an MR-US fusion biopsy program

There is growing evidence that MRI-ultrasound (MR-US)-targeted biopsy (TB) has high detection rates of clinically significant prostate cancer (PCa) compared to standard transrectal ultrasound (TRUS)-guided biopsy. A radiologist plays a significant role in MR-US fusion biopsy planning. Here, we discu...

Full description

Saved in:
Bibliographic Details
Published inAbdominal imaging Vol. 45; no. 12; pp. 4023 - 4027
Main Authors Sheridan, Alison, Maroni, Paul, Patel, Nayana U.
Format Journal Article
LanguageEnglish
Published New York Springer US 01.12.2020
Springer Nature B.V
Subjects
Biopsy
Gastroenterology
Hepatology
Imaging
Magnetic resonance imaging
Medicine
Medicine & Public Health
Prostate cancer
Radiology
Special section: Prostate cancer update
Ultrasonic imaging
Ultrasound
United States > US
MRI targeted prostate biopsy
Prostate Cancer
MRI-US fusion biopsy
Prostate MRI
Online AccessGet full text

Cover

More Information
Summary:There is growing evidence that MRI-ultrasound (MR-US)-targeted biopsy (TB) has high detection rates of clinically significant prostate cancer (PCa) compared to standard transrectal ultrasound (TRUS)-guided biopsy. A radiologist plays a significant role in MR-US fusion biopsy planning. Here, we discuss six simple steps that can help set up a successful MR-US fusion biopsy program in collaboration with the urologist.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:2366-004X
2366-0058
DOI:10.1007/s00261-020-02606-3